VIB-KU Leuven Center for Brain & Disease Research

What VIB-KU Leuven Center for Brain & Disease Research does

The VIB-KU Leuven Center for Brain & Disease Research (legally operating as VIB-KU Leuven Center for Neuroscience) is a non-profit academic research center jointly affiliated with VIB (Flemish Institute for Biotechnology) and KU Leuven University, headquartered in Leuven, Belgium. The center operates 19 principal research labs plus 2 affiliated labs, organized under leading scientists including the De Strooper lab, and focuses on understanding how the brain develops, ages, and functions, with disease-area emphasis on neurodegenerative disorders, movement disorders, and pain disorders. Its core scientific output spans molecular to systems-level neuroscience, bridging disciplines including AI, microelectronics, nanoscience, microfluidics, single cell analysis, and chimeric animal models.

The center operates a 12-platform technology infrastructure (Bioimaging, Biophysics, Electrophysiology, Flow Cytometry, Genomics & Nucleomics, Human Models, Mass Spectrometry, Neuroengineering, Neurophysiology, Rodent Models & Behaviour, Single Cell, and VIB Tech Watch) accessible to internal researchers and external collaborators. Distribution is academic-native: scientific publications, open-access channels, conference presentations, and collaborative consortia deliver research outputs globally, supported by an integrated community layer (PhD Association, Postdoc Association, Scientific Support Association, Inclusion & Diversity Committee, Eco Team).

Commercialization of research discoveries is mediated through the VIB ecosystem: the center partners with VIB Business Development for IP and deal flow, VIB Discovery Sciences and VIB Screening Core for early-stage drug discovery and high-throughput screening, and KU Leuven's Center for Drug Design & Discovery (CD3) for therapeutic translation. The Business Development Catalysts program and Flying Technicians service further accelerate spin-off creation and on-demand technical support. Revenue and commercial pricing are not publicly disclosed.

Name

VIB-KU Leuven Center for Brain & Disease Research

Legal name

VIB-KU Leuven Center for Neuroscience

Website

https://cbd.sites.vib.be

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

The VIB-KU Leuven Center for Brain & Disease Research is a non-profit neuroscience research center jointly run by VIB and KU Leuven in Belgium, operating 21 labs and 12 technology platforms to study brain development, aging, and neurodegenerative, movement, and pain disorders.

Ownership category

akta.pro rank

Product category

Neuroscience Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Translational Medicine & Biomarkers (HLAIALAF)

akta.pro secondary industries

AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)

Keywords

• Neuroscience research
• Brain disease research
• Neurodegenerative disease studies
• Molecular neuroscience platforms
• Academic biotech research

Headquarters

HQ city

Leuven

HQ country

Belgium

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Distribution channels1 record

Marketing channels3 records

Core offering

The center operates a multi-platform technology infrastructure for neuroscience research, spanning Bioimaging, Biophysics, Electrophysiology, Flow Cytometry, Genomics & Nucleomics, Human Models, Mass Spectrometry, Neuroengineering, Neurophysiology, Rodent Models & Behaviour, and Single Cell analysis. It conducts fundamental and disease-oriented research into brain development, aging, function, and neurodegenerative, movement, and pain disorders across 19 research labs plus 2 affiliated labs. It also supports commercialization of research outputs through partnerships with VIB Business Development, VIB Discovery Sciences, VIB Screening Core, and the KU Leuven Center for Drug Design & Discovery.

Product overview

The VIB-KU Leuven Center for Neuroscience is a research institution offering a multi-platform technology infrastructure supporting neuroscience research. The center operates multiple specialized technology platforms including Bioimaging, Biophysics, Electrophysiology, Flow Cytometry, Genomics & Nucleomics, Human Models, Mass Spectrometry, Neuroengineering, Neurophysiology, Rodent Models & Behaviour, and Single Cell analysis. These platforms are accessible to internal researchers and external collaborators to support research into brain development, aging, function, and neurodegenerative, movement, and pain disorders. The center also participates in innovation through VIB Business Development, VIB Discovery Sciences, VIB Screening Core, Center for Drug Design & Discovery, and Flying Technicians services.

Differentiator

Problem solved

Functional benefit

Products and services

• Bioimaging Technology Platform Advanced microscopy and imaging platform providing neuroimaging and cellular imaging capabilities for neuroscience research.
• Biophysics Technology Platform Biophysics platform supporting molecular and cellular analysis for brain and disease research.
• Electrophysiology Technology Platform Electrophysiology platform for studying electrical properties and signaling in neural systems.
• Flow Cytometry Technology Platform Flow cytometry technology for cell analysis and sorting in neuroscience research.
• Genomics and Nucleomics Technology Platform Genomics and nucleomics platform for genetic and nuclear analysis in brain research.
• Human Models Technology Platform Human-derived model systems for studying brain development, aging, and disease.
• Mass Spectrometry Technology Platform Mass spectrometry technology for proteomic and metabolomic analysis in disease research.
• Neuroengineering Technology Platform Neuroengineering platform combining microelectronics and nanoscience for neural research.
• Neurophysiology Technology Platform Neurophysiology technology for studying neural function and communication.
• Rodent Models and Behaviour Technology Platform Animal model and behavioral analysis platform for studying neurological disorders in rodent models.
• Single Cell Technology Platform Single-cell analysis platform for studying individual cell populations in brain tissue.
• VIB Tech Watch Initiative Technology scouting and evaluation initiative for emerging research technologies supporting the center's research programs.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Five partnerships are on record, tiered core and minor.

• VIB Business DevelopmentcoreStrategic or Co-development PartnerPartnership with VIB's central business development team for commercializing research discoveries and managing intellectual property
• VIB Discovery SciencescoreStrategic or Co-development PartnerCollaboration with VIB Discovery Sciences for early-stage drug discovery and validation activities
• VIB Screening CorecoreTechnology or IntegrationAccess to high-throughput screening facilities for compound libraries and genetic screens
• Center for Drug Design & Discovery (CD3)coreStrategic or Co-development PartnerPartnership with KU Leuven's drug discovery center for translating basic research into therapeutic candidates
• Business Development CatalystsminorGTM or Marketing PartnerSupport program for accelerating commercialization of research outcomes and spin-off creation

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• UK Dementia Research Institute: UK-wide non-profit institute dedicated to understanding the mechanisms of dementia and neurodegenerative diseases. Comparable as a multi-center, non-profit neurodegenerative disease research organization with strong translational focus.
• Allen Institute for Brain Science: Seattle-based non-profit research organization dedicated to accelerating understanding of the brain in health and disease. Highly comparable as a similarly-structured non-profit neuroscience research center with multi-platform technology infrastructure and a strong technology-platform-as-a-service model.
• Max Planck Institute for Brain Research: Frankfurt-based Max Planck Institute dedicated to understanding how the brain works at the molecular, cellular, and circuit level. Directly comparable as a European non-profit neuroscience research center with similar disease-focused and basic-research mission.
• McGovern Institute for Brain Research: MIT-based institute dedicated to understanding the brain in health and disease. Comparable as an academic-affiliated, multi-lab neuroscience research institute with strong technology platform infrastructure and PI-led lab model.
• Zuckerman Mind Brain Behavior Institute (Columbia): Columbia University's neuroscience institute focused on understanding the brain and behavior. Comparable as a major academic neuroscience research center with multi-platform technology infrastructure and disease-oriented research programs.
• Champalimaud Research: Lisbon-based non-profit neuroscience and cancer research center within the Champalimaud Foundation. Comparable as a European non-profit research center with systems neuroscience and disease-focused research, plus a translational orientation.
• Janelia Research Campus (HHMI): HHMI's research campus in Ashburn, Virginia, focused exclusively on neuroscience and structural biology. Comparable as a non-profit research institute with a small number of highly specialized labs, advanced imaging and physiology platforms, and a model of long-horizon basic research.

Broad incumbents

• Salk Institute for Biological Studies: La Jolla-based non-profit biological research institute with significant neuroscience research among broader biology programs. Comparable as a non-profit research institution with PI-led labs and translational pathways, though broader in scope.
• Karolinska Institutet (Department of Neuroscience): Sweden's premier medical university with a substantial neuroscience research department. Comparable as a European academic neuroscience research organization with PI-led labs and translational pipelines, though broader in institutional scope.

Emerging players

• Denali Therapeutics: US-based biotech developing therapeutics for neurodegenerative diseases. Comparable because it translates academic neuroscience research — much of which originates in research centers like this one — into commercial CNS therapeutics, representing a potential commercialization pathway/spin-off model for VIB-KU Leuven research outputs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/CBD_VIB
• Facebookfacebook.com/CenterforBrainandDiseaseResearch
• LinkedInlinkedin.com/company/centerbraindiseaseresearch

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VIB-KU Leuven Center for Brain & Disease Research